Avecho Biotechnology Limited (AVEFF)

USD 0.0

(0.0%)

Revenue Summary of Avecho Biotechnology Limited

  • Avecho Biotechnology Limited's latest annual revenue in 2023 was 473.55 Thousand AUD , down -60.74% from previous year.
  • Avecho Biotechnology Limited's latest quarterly revenue in 2024 Q2 was 156.09 Thousand AUD , down 0.0% from previous quarter.
  • Avecho Biotechnology Limited reported a annual revenue of 1.2 Million AUD in annual revenue 2022, up 51.99% from previous year.
  • Avecho Biotechnology Limited reported a annual revenue of 793.6 Thousand AUD in annual revenue 2021, up 106.33% from previous year.
  • Avecho Biotechnology Limited reported a quarterly revenue of 156.09 Thousand AUD for 2024 Q1, up 475.74% from previous quarter.
  • Avecho Biotechnology Limited reported a quarterly revenue of 446.43 Thousand AUD for 2023 Q2, up 100.0% from previous quarter.

Annual Revenue Chart of Avecho Biotechnology Limited (2023 - 1993)

Historical Annual Revenue of Avecho Biotechnology Limited (2023 - 1993)

Year Revenue Revenue Growth
2023 473.55 Thousand AUD -60.74%
2022 1.2 Million AUD 51.99%
2021 793.6 Thousand AUD 106.33%
2020 384.62 Thousand AUD -90.92%
2019 4.23 Million AUD 238.42%
2018 1.25 Million AUD 8.86%
2017 1.15 Million AUD -27.56%
2016 1.58 Million AUD -27.49%
2015 2.19 Million AUD 18.57%
2014 1.84 Million AUD 34.23%
2013 1.37 Million AUD 7.17%
2012 1.28 Million AUD -48.97%
2011 2.51 Million AUD -46.01%
2010 4.66 Million AUD 378.44%
2009 974 Thousand AUD -61.16%
2008 2.5 Million AUD 58.13%
2007 1.58 Million AUD 15.01%
2006 1.37 Million AUD 649.46%
2005 184 Thousand AUD 0.0%
2004 - AUD -100.0%
2003 240.2 Thousand AUD 72.79%
2002 139.01 Thousand AUD 0.0%
2001 - AUD 0.0%
2000 - AUD 0.0%
1999 - AUD 0.0%
1998 - AUD 0.0%
1997 - AUD 0.0%
1996 - AUD 0.0%
1995 - AUD 0.0%
1994 - AUD 0.0%
1993 - AUD 0.0%

Peer Revenue Comparison of Avecho Biotechnology Limited

Name Revenue Revenue Difference
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -516.916%
CSL Limited 14.69 Billion USD 99.997%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 96.998%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -2587.424%
Institute of Biomedical Research Corp. - USD -Infinity%
Evofem Biosciences, Inc. 18.21 Million USD 97.401%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.615%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 91.976%
Marizyme, Inc. 645.81 Thousand USD 26.673%
Genus plc 668.8 Million USD 99.929%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -15.454%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1098.317%
MultiCell Technologies, Inc. 49.32 USD -960060.178%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.048%
EV Biologics, Inc. 48.9 Thousand USD -868.407%
Q BioMed Inc. 284.35 Thousand USD -66.537%
Emmaus Life Sciences, Inc. 29.59 Million USD 98.4%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -576.501%
Skye Bioscience, Inc. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 97.795%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -525.364%
Intellipharmaceutics International Inc. 65.72 Thousand USD -620.471%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 28.086%
Neon Bloom, Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.807%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -378.363%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.961%
HST Global, Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -47302.503%
Enzolytics Inc. 52.79 Thousand USD -796.945%
Resverlogix Corp. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 22.181%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 75.489%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.674%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 15.09%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -237.667%
GlobeStar Therapeutics Corporation - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 23.297%
ONE Bio Corp. 52.29 Million USD 99.094%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.944%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 52.537%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.021%
BioStem Technologies, Inc. 16.68 Million USD 97.162%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -100.182%
Regen BioPharma, Inc. 236.56 Thousand USD -100.182%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 65.409%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 0.038%
SYBLEU INC 11.69 Thousand USD -3948.829%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 93.92%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -3542.7%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1097.832%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 85.779%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 92.895%
IntelGenx Technologies Corp. 1.03 Million USD 54.422%
Gelesis Holdings, Inc. 25.76 Million USD 98.162%
CSL Limited 14.8 Billion USD 99.997%
Cellectis S.A. 755 Thousand USD 37.278%